KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 108 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 4.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $174,000 | -23.0% | 12,000 | -47.8% | 0.13% | -15.5% |
Q2 2022 | $226,000 | -33.3% | 23,000 | 0.0% | 0.16% | -25.1% |
Q1 2022 | $339,000 | +11.5% | 23,000 | 0.0% | 0.21% | +48.9% |
Q4 2021 | $304,000 | -24.2% | 23,000 | 0.0% | 0.14% | -5.4% |
Q3 2021 | $401,000 | -27.2% | 23,000 | 0.0% | 0.15% | +13.1% |
Q2 2021 | $551,000 | – | 23,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |